Helen Sabzevari - May 31, 2024 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Role
President and CEO, Director
Signature
/s/ Helen Sabzevari, by Donald P. Lehr, as attorney-in-fact
Stock symbol
PGEN
Transactions as of
May 31, 2024
Transactions value $
$0
Form type
4
Date filed
5/31/2024, 07:03 PM
Previous filing
Apr 9, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGEN Option to Purchase Common Stock (Right to Buy) Award $0 +1.8M $0.00 1.8M May 31, 2024 Common Stock 1.8M $1.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest 25% on May 31, 2025 and in equal monthly installments for three years thereafter.